News
3 Mistakes to Avoid if the Stock Market Crashes in 2025
In the two-year period between 2023 and the end of last year, the S&P 500 (SNPINDEX: ^GSPC) rocketed 53.2% higher while the Nasdaq Composite (NASDAQINDEX: ^IXIC) surged a mind-numbing 84.5%. So
Warren Buffett Isn't Buying His Favorite Stock, but He's Been Scooping Up Shares of 3 Value Stocks Since 2025 Began
Few if any investors have earned Wall Street's attention quite like Berkshire Hathaway's (NYSE: BRK.A)(NYSE: BRK.B) billionaire CEO, Warren Buffett. In his 60 years at the helm, the aptly named
Has Nvidia Stock Become Too Cheap to Ignore?
Nvidia (NASDAQ: NVDA) has become a stock market giant thanks to its dominance in one of today's highest-growth markets: artificial intelligence (AI), a $200 billion market that analysts say is
2 Top Growth Stocks to Buy Hand Over Fist in the Nasdaq Correction
The Nasdaq has been a surefire winner over the past two years, soaring in the double digits annually. Investors were optimistic about the potential for a lower interest rate environment ahead and
Here's How Much You Should Have Invested for Retirement at Age 67
What's your magic number? That is to say, how much savings do you need to retire comfortably? According to a 2024 survey of 4,588 Americans performed by insurer Northwestern Mutual, $1.46 million
Elon Musk Makes a Massive Prediction for Tesla's Profits
Tesla (NASDAQ: TSLA) is one of the best performing stocks of the last 15 years, up 17,430% since its initial public offering. And yet the shares are down 42% from all-time highs set at the end of
3 Reasons Brookfield Renewable Is a Long-Term Buy for 2030 and Beyond
Brookfield Renewable (NYSE: BEPC)(NYSE: BEP) operates one of the world's largest publicly traded renewable energy and decarbonization platforms. It has a diversified portfolio of hydroelectric,
Better Buy in 2025: Nvidia Stock or Bitcoin?
Nvidia (NASDAQ: NVDA) and Bitcoin (CRYPTO: BTC) don't have much in common, but they have been two of the best-performing investments over the last five years, obliterating the S&P 500 (SNPINDEX:
Nasdaq Stock Correction: 4 Magnificent Artificial Intelligence (AI) Stocks That Make for Slam-Dunk Buys Right Now
Over the last two weeks, Wall Street has sent a stern reminder to the investment community that stocks can, indeed, move in both directions.
Following an unwavering rally spanning almost
Precisely How Bad Is Rocket Lab's Neutron News?
Rocket Lab (NASDAQ: RKLB) stock tumbled ahead of earnings last week, but it's been making up ground since -- and rightly so. Rumors of rocket launch delays and wobbly stock price notwithstanding
EQS-Adhoc: alstria office REIT-AG: alstria intends to issue a corporate bond with a nominal value of EUR 500,000,000 and announces invitation to tender for purchase existing corporate bonds
Social Security Has a Revenue Problem. The Solutions to Fix It Aren't Great.
If you've been hearing rumors that Social Security on the verge of going bankrupt, you should know that the program is not about to run out of money. Social Security can't run out of money because
EQS-News: Hypoport delivers solid growth and a healthy rise in earnings despite mixed market conditions
A Majority of Businesses Intrigued by the Potential of AI in Achieving Sustainability Goals Whilst Energy Consumption Concerns Persist
Nasdaq Correction: 3 Things Every Investor Should Know
The Nasdaq, along with the S&P 500 and the Dow Jones Industrial Average, roared higher over the past two years, delivering double-digit annual gains. And the momentum continued into this year as
Why Coca-Cola's Rally Makes PepsiCo Stock Look Even More Attractive
It is virtually impossible not to look at Coca-Cola (NYSE: KO) if you are considering buying PepsiCo (NASDAQ: PEP) and vice versa. The two companies are iconic and globally dominant beverage giants
2 AI Stocks Down More Than 45% to Buy in March
The rise of artificial intelligence (AI) technology offers the promise of wealth-building returns for investors who hold the right stocks. Estimates suggest that the productivity gains driven by AI
Is the SPDR S&P 500 ETF Trust the Smartest Investment You Can Make Today?
With the three major indexes slipping over the past few weeks, now may not seem like the best time to invest in stocks. It's always more tempting to buy when we see a particular stock or asset
This Nvidia-Backed IPO Grew 737% Last Year and Is About to Go Public: What Investors Should Know About CoreWeave
There haven't been a ton of initial public offerings (IPOs) in recent years, let alone interesting, prominent companies with the potential to take on the top tech stocks in the market. However, one
Think Nvidia Stock Is Expensive? This Chart Might Change Your Mind.
Artificial intelligence (AI) is rapidly transforming the global economy. The technology's ability to automate complex workflows and deliver predictive insight has ushered in a new era of business
Did Taiwan Semiconductor Just Say "Checkmate" to Intel?
During President Biden's tenure in the Oval Office, his administration made it a point to boost investment in domestic manufacturing. One of the administration's accomplishments came in 2022, when
This Brilliant Fintech Stock Is Down 32%. Buy It Before It Sets a New All-Time High.
Nobody enjoys stock drawdowns. They can provide buying opportunities for high-quality businesses, sure, but it is never fun to see your personal wealth go down in value. Right now, stocks listed in
Getting a Tax Refund? 3 Exciting Stocks to Buy With Your Refund Check.
The Internal Revenue Service (IRS) has already processed more than 29.6 million tax refunds this year, up 2.3% from last year. The average taxpayer is getting $3,453 apiece, a 7.5% increase from
Could Investing in This Quantum Computing Stock Be Like Buying Nvidia Prior to the Dawn of the Artificial Intelligence (AI) Revolution?
Whenever a new megatrend emerges, it is not uncommon for small, previously little-known companies to suddenly become household names. Underneath the artificial intelligence (AI) umbrella, an area
This Weight Loss Stock Could Skyrocket by 462%, According to Wall Street
Last year, Viking Therapeutics, a mid-cap biotech, made waves after it reported excellent phase 2 results for an investigational medicine for weight loss, the industry's hottest and perhaps



